NasdaqCM - Delayed Quote USD
Cyclacel Pharmaceuticals, Inc. (CYCCP)
4.8700
+0.0700
+(1.46%)
At close: April 23 at 4:00:00 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
4,094
8,805
28,050
43,136
Total Liabilities Net Minority Interest
6,268
8,198
7,617
5,443
Total Equity Gross Minority Interest
-2,174
607
20,433
37,693
Total Capitalization
-2,174
607
20,433
37,693
Common Stock Equity
-2,174
607
20,433
37,693
Capital Lease Obligations
--
37
106
30
Net Tangible Assets
-2,174
607
20,433
37,693
Working Capital
-2,594
-717
16,900
35,529
Invested Capital
-2,174
607
20,433
37,693
Tangible Book Value
-2,174
607
20,433
37,693
Total Debt
--
37
106
30
Share Issued
8,859.1330
1,058.8920
835.9450
666.2090
Ordinary Shares Number
8,859.1330
1,058.8920
835.9450
666.2090
Preferred Shares Number
335.2730
335.2730
335.2730
335.2730
12/31/2021 - 11/30/2005
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RKVTF RAKOVINA THERAPEUTICS INC
0.0360
-0.28%
ARMP Armata Pharmaceuticals, Inc.
1.3519
+2.42%
CYCN Cyclerion Therapeutics, Inc.
3.0100
+2.03%
ORGS Orgenesis Inc.
2.4900
+12.67%
TOVX Theriva Biologics, Inc.
1.4131
-1.18%
ATHE Alterity Therapeutics Limited
3.5400
+0.57%
AVTX Avalo Therapeutics, Inc.
4.8800
-1.41%
CAMP CAMP4 THERAPEUTICS CORPORATION
1.9900
+0.51%
TCRT Alaunos Therapeutics, Inc.
2.6800
+8.94%
ZVSA ZyVersa Therapeutics, Inc.
0.7151
+1.56%